Experts in the treatment of melanoma answered listeners’ questions this week during CancerCare’s free Connect Education Workshop, Metastatic Melanoma Treatment Update. Melanoma, a serious form of skin cancer, is one of the fastest growing cancers worldwide.
The workshop coincided with the FDA’s approval of “breakthrough” drug Yervoy, the first drug shown to prolong the lives of people with metastatic melanoma. Listen to the workshop.
Yervoy’s manufacturer, Bristol-Myers Squibb, is expected to present studies on its effectiveness at the 2011 American Society of Clinical Oncology (ASCO) Annual Meeting, to be held June 4-8 in Chicago, IL.
Yervoy is an immunotherapy drug that harnesses the body’s own immune system to fight tumors. A recent New York Times article about the development of Yervoy described how it works by “essentially disabling a break on the immune system.”
CancerCare’s offers free, professional services for people affected by melanoma. The Melanoma Helpline, a partnership between CancerCare and the Melanoma Research Foundation (MRF), is staffed by professional oncology social workers who provide free telephone counseling and reliable information about resources and ways to cope with melanoma. Call The Melanoma Helpline at 877-MRF-6460 (877-673-6460).
Teb’s Troops, a non-profit organization dedicated to raising funds and awareness for people affected by melanoma, will hold its annual 5K in Chicago, IL on Sunday, July 24. Teb’s Troops provides a generous grant from funds raised at this event to support CancerCare’s free, professional services for anyone facing melanoma. Visit Teb’s Troops’ Facebook page to learn more.